We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Determinants of Quality of Life Related to Health in Alzheimer Disease

This study is currently recruiting participants.
Verified June 2016 by CHU de Reims
Sponsor:
ClinicalTrials.gov Identifier:
NCT01570322
First Posted: April 4, 2012
Last Update Posted: June 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
CHU de Reims
April 2, 2012
April 4, 2012
June 9, 2016
Not Provided
Not Provided
Health-Related Quality of Life (HRQOL) Assessment
HRQOL Assessment
Complete list of historical versions of study NCT01570322 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Determinants of Quality of Life Related to Health in Alzheimer Disease
Not Provided

Study the factors that explain Health-Related Quality of Life (HRQL) in patients with Alzheimer disease including:

  • The influence of the environment (physical and human) on Health-Related Quality of Life (HRQL),
  • The influence of non-drug and drug treatments on Health-Related Quality of Life (HRQL),
  • The influence of formal and informal help mobilized,
  • The influence of interactions "patient - caregiver" on Health-Related Quality of Life (HRQL),
  • The influence of the ratio necessary cost on available resources on Health-Related Quality of Life (HRQL)
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
  • Patients with Alzheimer disease (DSM IV - Diagnostic and Statistical Manual of Mental Disorders - and NINCDS/ADRDA - National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association)
  • Patients with MMSE (Mini Mental State Examination) > or = 10
Alzheimer Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
400
Not Provided
Not Provided

Inclusion Criteria:

  • Patients with Alzheimer disease (DSM IV and NINCDS-ADRDA)
  • Patients with MMSE (Mini Mental State Examination) > or = 10
  • Out patients

Exclusion Criteria:

  • Severe sensory disturbances,
  • Non French speaking
Sexes Eligible for Study: All
75 Years and older   (Senior)
No
Contact: Jean-Luc NOVELLA, MD PhD jlnovella@chu-reims.fr
France
 
 
NCT01570322
PN09004
No
Not Provided
Not Provided
CHU de Reims
CHU de Reims
Not Provided
Not Provided
CHU de Reims
June 2016